title: Lipase activities in post-heparin plasma and tissues, and susceptibilities of lipoproteins in experimental diabetic rats.
abstract: Heparin administration to diabetic rats caused no change in VLDL, an increase in IDL and a decrease in LDL on electrophoretic analysis of plasma lipoproteins, while the administration to control rats markedly decreased VLDL and increased IDL and LDL. Both hepatic triglyceride lipase (HTGL) and lipoprotein lipase (LPL) activities in the postheparin plasma were lower in the diabetic rats than in the controls, and the reduction of HTGL activity was greater than that of LPL activity in the diabetic rats. The LPL activity in the adipose tissue was lower in the diabetic rats than in the controls, but the activities in the cardiac and skeletal muscles were similar in the two rats. The HTGL-catalyzed fatty acid (FA) releases from the diabetic VLDL and IDL were lower than those from the normal rat VLDL and IDL, while the LPL-catalyzed FA release in the diabetic rats was not different from those in the controls. The decreases in LPL and HTGL activities and the markedly impaired susceptibility of IDL to HTGL coincide well with the postheparin changes in plasma lipoproteins in diabetic rats, an increase in IDL and a decrease in LDL.
authors.affiliation: Department of Laboratory and Clinical Medicine, Ehime University Medical School, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Saheki
authors.forename: Y
authors.initials: Y
authors.lastname: Hitsumoto
authors.forename: N
authors.initials: N
authors.lastname: Takeuchi
authors.forename: H
authors.initials: H
authors.lastname: Takase
authors.forename: Y
authors.initials: Y
authors.lastname: Nomura
authors.forename: H
authors.initials: H
authors.lastname: Igimi
authors.forename: K
authors.initials: K
authors.lastname: Uchida
mesh_terms: D000273:Adipose Tissue / Q000201:enzymology; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D005227:Fatty Acids / Q000378:metabolism; D006493:Heparin / Q000494:pharmacology; D006949:Hyperlipidemias / Q000201:enzymology*; D066298:In Vitro Techniques; D008049:Lipase / Q000502:physiology*; D008071:Lipoprotein Lipase / Q000502:physiology*; D008074:Lipoproteins / Q000378:metabolism*; D008297:Male; D009132:Muscles / Q000201:enzymology; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000925:Anticoagulants; D005227:Fatty Acids; D008074:Lipoproteins; D006493:Heparin; D008049:Lipase; D008071:Lipoprotein Lipase